Antigen-affinitätsgereinigte Polyklonale Antikörper

Anti-Rat MIP-1α (CCL3)

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 500-P77

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits pre-immunized with highly pure recombinant Rat MIP1α. Anti-Rat MIP1α specific antibody was purified by affinity chromatography employing immobilized Rat MIP1α matrix.

Immunogen: E.coli derived Recombinant Rat MIP-1α (CCL3) (PeproTech catalog# 400-15)

Sandwich ELISA: To detect Rat MIP-1α by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Rat MIP-1α (500-P77Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Rat MIP-1α.

Anti-Rat MIP-1α (CCL3) Sandwich ELISA

Western Blot: To detect Rat MIP-1α by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Rat MIP-1α is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Rat MIP-1α (CCL3) Western Blot Reduced Anti-Rat MIP-1α (CCL3) Western Blot Unreduced


Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

Country Of Origin: USA

Not for human use.

Research Interest


First Author
Rius, C
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.
Journal of immunology (Baltimore, Md. : 1950); 185(6) pg3718-27
PubMed Id
First Author
Mateo, T
A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles.
Blood; 110(6) pg1895-902
PubMed Id
First Author
Abu-Taha, M
Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan.
Journal of immunology (Baltimore, Md. : 1950); 183(2) pg1393-402
PubMed Id